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Abstract. Electronic health records (EHR) are increasingly being used for 
observational research at scale. In the UK, we have established the CALIBER 
research resource which utilizes national primary and hospital EHR data sources and 
enables researchers to create and validate longitudinal disease phenotypes at scale. 
In this work, we will describe the core components of the resource and provide 
results from three exemplar research studies on high-resolution epidemiology, 
disease risk prediction and subtype discovery which demonstrate both the 
opportunities and challenges of using EHR for research. 
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1. Introduction 
Electronic Health Records (EHR) are a rich source of information on human diseases 
[1]. EHR are generated during routine patient interactions in primary or secondary 
healthcare. EHR can contain information on diagnoses, symptoms. surgical procedures 
and interventions, prescriptions, laboratory biomarkers (e.g. high-density lipoprotein 
cholesterol) and physiological measurements (e.g. blood pressure (BP), body mass 
index).  Linking EHR which span primary care and hospital healthcare settings in the 
United Kingdom (UK) can enable researchers to create longitudinal phenotypes that 
accurately capture disease onset, severity, and progression [2]. The process of defining 
disease phenotypes in EHR data however is challenging and time-consuming since EHR 
are variably structured, fragmented, curated using different clinical terminologies and 
collected for purposes other than medical research [3].  
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2. Objective 
Here we present and describe a state-of-the-art phenomics resource, CALIBER, for 
developing, validating and sharing reproducible phenotypes in national structured EHR 
in the UK. We additionally briefly describe contemporary research exemplars using 
CALIBER data for translational research: a) disaggregating disease endpoints through 
high resolution clinical epidemiology, b) disease risk prediction using supervised 
machine learning approaches, and c) subtype discovery using unsupervised learning.  
3. Methods 
3.1 CALIBER phenomics resource 
We implemented and applied a rule-based phenotyping framework [4] for extracting 
information on diseases (status, severity, onset), lifestyle risk factors and biomarkers 
and applied it to a sample of 15 million individuals. CALIBER utilizes data from three 
national EHR sources: a) primary care EHR from the Clinical Practice Research 
Datalink (CPRD), b) administrative data on diagnoses and procedures during admission 
to hospitals from Hospital Episode Statistics (HES), and c) cause-specific mortality 
information from the Office for National Statistics (ONS) death register. Data were 
recorded using five controlled clinical terminologies: a) Read (primary care), b) ICD-
10 (hospital diagnoses, causes of death), c) ICD-9 (causes of death <1999), and d) 
OPCS-4 (surgical procedures), and d) DM+D (prescriptions in primary care). 
3.2 Contemporary research exemplars 
We present three contemporary research exemplars utilizing the CALIBER resource 
and phenotyping framework: a) high resolution epidemiology: we calculated Hazard 
ratios (HRs) based on disease-specific Cox models with time since study entry as the 
timescale, adjusted for baseline age and stratified by sex and primary care practice and 
report the associations of systolic and diastolic BP with 12 different cardiovascular 
diseases (CVD), b) disease risk prediction: using a global vectors model[5],  we trained 
clinical concept embeddings from hospitalization diagnosis and procedure information 
recorded in HES and evaluated them for predicting for the risk of admission to hospital 
in heart failure (HF) patients, and c) subtype discovery: we applied dimensionality 
reduction using multiple correspondence analysis and data clustering using k-means to 
a cohort of Chronic Obstructive Pulmonary Disease (COPD) patients in order to 
identify and characterize novel and clinically-meaningful disease subtypes.  
4. Results 
4.1 CALIBER phenomics resource 
We created an iterative, rule-based EHR phenotyping approach which combined 
domain expert input with data exploration. We curated >90,000 ontology terms from 
five clinical terminologies and created 51 phenotyping algorithms (35 
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diseases/syndromes, ten biomarkers, six lifestyle risk factors). Phenotype validation is a 
critical step in the process, and we provided up to six approaches for validating 
phenotypes: a) the ability to replicate aetiological and prognostic associations reported 
from non-EHR studies, b) case note review for Positive Predictive Value (PPV) 
reporting, c) the ability to replicate associations with genetic variants from non-EHR 
Genome-Wide Association Studies, d) algorithm performance in external populations, 
and e) cross-EHR-source concordance and stratification of populations.  
For each phenotype, we created a textual description with details on the 
implementation logic, the pre-processing steps and implementation steps. For some 
algorithms, we generated flowchart descriptions to describe how different components 
are combined to form the finalized phenotype and for facilitating the translation to 
machine-code (e.g. SQL) for execution and data extraction. Algorithms are curated on 
an open-access resource, the CALIBER Portal (https://www.caliberresearch.org/portal), 
[6,7] and have been used in >60 publications from national and international research 
groups. Each phenotype page on the Portal2 contains sufficient implementation and 
validation information for external researchers to re-use the algorithm. 
4.2 Contemporary research exemplars 
High resolution epidemiology: In a cohort of 1.25 million patients, we reported [8] 
highly-heterogeneous associations between BP and CVD disease endpoints: high 
systolic BP was more strongly associated with stable angina, Hazard Ratio (HR) 0.41 
[95% CI 1.36-1.46] than diastolic whereas diastolic BP had the strongest association 
with abdominal aortic aneurysm (HR 1.45 [95% CI 1.34–1.56]). We have undertaken 
similar analyses in other conventional CVD risk factors e.g. smoking [9], type-II 
diabetes [10], alcohol [11], social deprivation [12], heart rate [13], sex [14].  
Disease risk prediction:  We trained clinical concept embeddings [15] from 2,447 ICD-
9, 10,527 ICD-10 and 6,887 OPCS-4 terms across 2,779,598 hospitalizations in the UK 
Biobank. In the UK Biobank, we identified 4,581 HF cases (using the CALIBER HF 
phenotype [16,17])(30.52% female) and matched them to 13,740 controls. Clinical 
concept embeddings performed marginally better (AUROC 0.6965) than one-hot 
encoding of hospitalization data for predicting admission to hospital due to HF. 
Disease subtype discover: In the CPRD [18], we identified 30,961 current and former 
smokers diagnosed with COPD and extracted 15 clinical features including risk factors 
and comorbidities. Using clustering, we identified five clinically-meaningful COPD 
clusters with distinct dominant clinical profiles (e.g. anxiety/depression, frailty, CVD, 
obesity and atopy) and different healthcare utilization and exacerbation profiles. 
5. Conclusions 
In this manuscript, we described the CALIBER resource as a framework for using 
national EHR from primary and secondary health care, disease and national mortality 
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registries. Challenges remain with regards to scaling the phenotyping efforts to 
thousands of diseases and for recreating the life course of disease [19] .  
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